Skip to main content Scroll Top

News

  • Home
  • Alzheimer
  • Translation from Preclinical Research to Clinical Trials: Brain-Gut Photobiomodulation Therapy for Alzheimer’s Disease
Most Viewed Posts
Clear Filters
REGEnLIFE: a revolution in the treatment of neurodegenerative diseases
REGEnLIFE: a revolution in the treatment of neurodegenerative diseases
7 February 2025
The neuroprotective effect of a new photobiomodulation technique on Aβ25-35 peptide-induced toxicity dramatically impact gut microbiota dysbiosis
11 July 2019
Clinical Trials on Alzheimer’s Disease (CTAD CHINA)
24 October 2023
11 March 2024

Translation from Preclinical Research to Clinical Trials: Brain-Gut Photobiomodulation Therapy for Alzheimer’s Disease

Read the article

Blivet G, Roman FJ, Delrieu J, Touchon J.

J Integr Neurosci. 2024 Mar 11;23(3):57. doi: 10.31083/j.jin2303057.

PMID: 38538226 Free article

Share this article

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.